Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer.

@article{Marcuello1988CisplatinAI,
  title={Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer.},
  author={Eugenio Marcuello and Emilio Alba and Gerard Gomez De Segura and M S{\'a}nchez Parra and Luisa De Andres and Antonio L{\'o}pez Pousa and Carlos Pallar{\'e}s and Josep Ram{\'o}n Germ{\`a} and Juan Jos{\'e} L{\'o}pez L{\'o}pez},
  journal={European journal of cancer & clinical oncology},
  year={1988},
  volume={24 4},
  pages={633-5}
}
Thirty-four patients with locally advanced or metastatic esophageal cancer were treated with cisplatin 35 mg/m2/day x 3 days in bolus, plus bleomycin 15 mg/day x 3 days, as an 18 h infusion, every 21-28 days. Twenty-nine are evaluable for response. Objective response was seen in 15 (52%, 95% confidence limits 35-69%) patients. Toxicity was mild. Twelve… CONTINUE READING